title: Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs.
abstract: Gadolinium (Gd) contrast agents are predominantly used for T(1) MR imaging. However, the high toxicity of Gd(3+) and potential side effects including nephrogenic systemic fibrosis have led to the search for alternative T(1) contrast agents. Since manganese (Mn) has paramagnetic properties with five unpaired electrons that permit high spin number, long electronic relaxation times, and labile water exchange, we evaluated Mn as a T(1) magnetic resonance imaging (MRI) contrast agent for lung imaging. Here we report on the design and synthesis of multifunctional lipid-micellar nanoparticles (LMNs) containing Mn oxide (M-LMNs) for MRI that can also be used for DNA and drug delivery. Oleic acid-coated MnO nanoparticles were encapsulated in micelles composed of polyethylene glycol (PEG-2000), phosphatidylethanolamine (PE), DC-cholesterol, and dioleoyl-phosphatidylethanolamine (DOPE). The particles are taken up in vitro by human embryonic kidney (HEK293), Lewis lung carcinoma (LLC1), and A549 cells and are devoid of cytotoxicity. When administered to mice intranasally, they preferentially accumulate in the lungs. In vitro phantom and ex vivo lung MRI results confirmed that M-LMNs are able to enhance T(1) MRI contrast. M-LMNs loaded with plasmid DNA and/or doxorubicin are efficiently taken up by HEK293 cells in vitro and by target cells in vivo. Taken together, these results demonstrate that M-LMNs are capable of simultaneously providing MRI contrast and DNA and/or drug delivery to target cells in the lung and therefore may prove useful as a lung theranostic, especially for lung cancers.
authors: Molecular Medicine Department, Morsani College of Medicine, University of South Florida, Box MDC7, 12901 Bruce B Downs, Tampa, FL 33612, United States.
authors: M
authors: M
authors: Howell
authors: J
authors: J
authors: Mallela
authors: C
authors: C
authors: Wang
authors: S
authors: S
authors: Ravi
authors: S
authors: S
authors: Dixit
authors: U
authors: U
authors: Garapati
authors: S
authors: S
authors: Mohapatra
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004247:DNA / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D018014:Gene Transfer Techniques; D057809:HEK293 Cells; D006801:Humans; D017895:Manganese Compounds / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D053768:Metal Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D008823:Micelles; D019301:Oleic Acid / Q000737:chemistry; D010087:Oxides / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D014018:Tissue Distribution
chemical_list: D017895:Manganese Compounds; D008823:Micelles; D010087:Oxides; D019301:Oleic Acid; C027424:manganese oxide; D004317:Doxorubicin; D004247:DNA
references: Nat Mater. 2004 Dec;3(12):891-5
references: 15568032
references: Nat Med. 1995 Jan;1(1):39-46
references: 7584951
references: ACS Nano. 2011 May 24;5(5):4131-44
references: 21524062
references: Pharm Res. 2012 Feb;29(2):362-74
references: 21842305
references: Trends Biotechnol. 2007 Dec;25(12):563-70
references: 17997181
references: Chem Rev. 2008 Jun;108(6):2064-110
references: 18543879
references: Pharm Res. 2010 Nov;27(11):2283-95
references: 20845067
references: Biomaterials. 2012 Aug;33(22):5574-83
references: 22579235
references: Angew Chem Int Ed Engl. 2007;46(28):5397-401
references: 17357103
references: Trends Mol Med. 2010 Dec;16(12):561-73
references: 21074494
references: Gene Ther. 2000 Jul;7(13):1156-65
references: 10918483
references: Angew Chem Int Ed Engl. 2009;48(2):321-4
references: 19040234
references: Bioprocess Biosyst Eng. 2010 Jan;33(1):21-30
references: 19636592
references: Tetrahedron. 2011 Nov 4;67(44):8431-8444
references: 22043109
references: ACS Nano. 2011 Dec 27;5(12):9480-93
references: 22032622
references: J Control Release. 2012 Oct 10;163(1):82-92
references: 22561339
references: Theranostics. 2012;2(7):714-22
references: 22896773
references: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11
references: 8248244
references: Mol Pharm. 2009 Mar-Apr;6(2):468-79
references: 19718800
references: J Control Release. 2004 Aug 27;98(3):415-26
references: 15312997
references: Science. 2002 Nov 29;298(5599):1759-62
references: 12459582
references: Clin Cancer Res. 2003 Jun;9(6):2335-41
references: 12796403
references: Hum Gene Ther. 1994 Sep;5(9):1089-94
references: 7833368
references: Int J Pharm. 2007 Sep 5;342(1-2):33-9
references: 17566677
references: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):162-73
references: 20860051
references: J Control Release. 2012 Jun 10;160(2):117-34
references: 22484195
references: Biochim Biophys Acta. 1995 May 4;1235(2):289-95
references: 7756337
references: Theranostics. 2012;2(1):45-54
references: 22272218
references: Nat Nanotechnol. 2009 Sep;4(9):598-606
references: 19734934
references: Colloids Surf B Biointerfaces. 2011 Jan 1;82(1):160-7
references: 20851578
references: Biomaterials. 2011 Oct;32(29):7139-50
references: 21726899
references: J Magn Reson Imaging. 2009 Dec;30(6):1268-76
references: 19938039
references: Eur Respir J. 1994 Mar;7(3):442-5
references: 8013599
references: Int J Pharm. 2010 May 10;390(2):198-207
references: 20116418
references: Radiographics. 2009 Oct;29(6):1565-74
references: 19959508
references: Gene Ther. 1997 Mar;4(3):199-209
references: 9135733